{"status": "ok", "totalResults": 12, "articles": [{"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Lupin to train over 1,000 graduates for pharma industry by 2020", "description": "Lupin has launched its #39;Learn and Earn#39; initiative in which candidate who has passed Standard 12 in the science stream with a minimum of 50 percent marks but are facing financial constraints are taken for three-year-long course during which they are pai\u2026", "url": "https://www.moneycontrol.com/news/business/lupin-to-train-over-1000-graduates-for-pharma-industry-by-2020-2924881.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/07/Lupin-770x433.jpg", "publishedAt": "2018-09-06T10:46:05Z", "content": "Pharmceutical giant, Lupin Limited expects to train more than 1,000 under graduates into pharma professionals by the year 2020 under its Learn and Earn Initiative, a senior company official said today. Lupin has launched its 'Learn and Earn' initiative in whi\u2026 [+1850 chars]"}, {"source": {"id": null, "name": "Dailycaller.com"}, "author": "Mark Anthony", "title": "Drug Proposal Could Be Major Job Creator In India, China", "description": "Experts say American consumers may end up facing increased risks when buying medicines", "url": "https://dailycaller.com/2018/09/06/major-job-creator-in-india-china/", "urlToImage": "https://cdn01.dailycaller.com/wp-content/uploads/2018/09/1004465254-594x594-e1536261929709.jpg", "publishedAt": "2018-09-06T19:25:48Z", "content": "Drug companies in India and China are drooling over the prospect that many American jobs in the pharmaceutical industry could soon be outsourced overseas. The reason? A recent announcement from the U.S. Food and Drug Administration (FDA) that it is exploring \u2026 [+3702 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Rob Merrick, Rob Merrick", "title": "UK taxpayers to foot bill for stockpiling medicines to prepare for no-deal Brexit", "description": "'We are talking to the pharmaceutical industry about the extra cost that they might have to incur,' Matt Hancock says", "url": "https://www.independent.co.uk/news/uk/politics/no-deal-brexit-medicine-stockpile-taxpayers-nhs-matt-hancock-a8525051.html", "urlToImage": "https://static.independent.co.uk/s3fs-public/thumbnails/image/2017/11/15/13/medicines.png", "publishedAt": "2018-09-06T08:11:42Z", "content": "Taxpayers will have to foot the bill for stockpiling NHS medicines to prepare for crashing out of the EU without a deal, the health secretary says. Matt Hancock revealed he was \u201ctalking to pharmaceutical industry about what extra costs the government should c\u2026 [+9743 chars]"}, {"source": {"id": null, "name": "Thehindubusinessline.com"}, "author": "Rajiv Nath", "title": "Profit-making device", "description": "No level-playing field in medical devices market", "url": "https://www.thehindubusinessline.com/opinion/columns/profit-making-device/article24884323.ece", "urlToImage": "https://www.thehindubusinessline.com/opinion/columns/4ppz1h/article24884321.ece/ALTERNATES/LANDSCAPE_615/BL07THINKMED1", "publishedAt": "2018-09-06T15:37:07Z", "content": "Rajiv Nath The Global Healthcare Access and Quality Index (2018) ranks India at 145 among 190 nations, lower than Bangladesh, Sudan and Equatorial Guinea. This ranking should drive the authorities and industry to change this landscape by ensuring affordable a\u2026 [+3231 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "PTI", "title": "Lupin to train over 1,000 graduates for pharma industry", "description": "Mumbai-headquartered Lupin has estimated that by the year 2020 they would be spending almost Rs 20 crore on this programme.", "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-to-train-over-1000-graduates-for-pharma-industry/articleshow/65705126.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65705685,width-1070,height-580,imgsize-37954,overlay-economictimes/photo.jpg", "publishedAt": "2018-09-06T11:05:16Z", "content": "Pharmceutical giant, Lupin Limited expects to train more than 1,000 under graduates into pharma professionals by the year 2020 under its Learn and Earn Initiative, a senior company official said today. Lupin has launched its 'Learn and Earn' initiative in whi\u2026 [+1852 chars]"}, {"source": {"id": null, "name": "Prnewswire.com"}, "author": null, "title": "Pharmaceutical Plastic Packaging Market Demand Increasing Owing to Price Efficiency, Stress-Free Usage & Transport, Sturdiness, and Appealing Structures: Radiant Insights, Inc.", "description": "SAN FRANCISCO, September 6, 2018 /PRNewswire/ -- The Global Pharmaceutical Plastic Packaging Market is estimated to develop at a substantial CAGR for the duration of the prediction. The plastic packaging estimated to observe substantial development above the \u2026", "url": "https://www.prnewswire.com/news-releases/pharmaceutical-plastic-packaging-market-demand-increasing-owing-to-price-efficiency-stress-free-usage-amp-transport-sturdiness-and-appealing-structures-radiant-insights-inc--840019087.html", "urlToImage": "/content/dam/prnewswire/common/prn_facebook_sharing_logo.jpg", "publishedAt": "2018-09-06T09:45:00Z", "content": "SAN FRANCISCO, September 6, 2018 /PRNewswire/ -- The Global Pharmaceutical Plastic Packaging Market is estimated to develop at a substantial CAGR for the duration of the prediction. The plastic packaging estimated to observe substantial development above the \u2026 [+5175 chars]"}, {"source": {"id": null, "name": "Prnewswire.com"}, "author": null, "title": "Global Pharmacovigilance and Drug Safety Software Market 2018-2024 - Rising Incidences of ADR & Globalization of Pharmacovigilance Driving Market Growth", "description": "DUBLIN, Sept. 6, 2018 /PRNewswire/ -- The \"Pharmacovigilance and Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode, By End Use (Pharmaceutical & Biotech Companies, CROs, BPOs), And Segment Forecasts, 2018 - 20\u2026", "url": "https://www.prnewswire.com/news-releases/global-pharmacovigilance-and-drug-safety-software-market-2018-2024---rising-incidences-of-adr--globalization-of-pharmacovigilance-driving-market-growth-300707990.html", "urlToImage": "https://mma.prnewswire.com/media/732750/Research_and_Markets.jpg?p=facebook", "publishedAt": "2018-09-06T12:45:00Z", "content": "DUBLIN, Sept. 6, 2018 /PRNewswire/ -- The \"Pharmacovigilance and Drug Safety Software Market Size, Share &amp; Trends Analysis Report By Functionality, By Delivery Mode, By End Use (Pharmaceutical &amp; Biotech Companies, CROs, BPOs), And Segment Forecasts, 2\u2026 [+4699 chars]"}, {"source": {"id": null, "name": "Prnewswire.com"}, "author": null, "title": "Flavonoids in Dietary Supplements Market - Global Forecast to 2022: Extrasynthese, Kemin Industries & Quercegen Pharma Hold Substantial Market Share", "description": "DUBLIN, Sept. 6, 2018 /PRNewswire/ -- The \"Flavonoids in Dietary Supplements Market: By form; By Flavonoid Class; By Application & By Geography - Forecast 2017-2022\" report has been added to ResearchAndMarkets.com's offering. Flavonoids are generally produces\u2026", "url": "https://www.prnewswire.com/news-releases/flavonoids-in-dietary-supplements-market---global-forecast-to-2022-extrasynthese-kemin-industries--quercegen-pharma-hold-substantial-market-share-300708155.html", "urlToImage": "https://mma.prnewswire.com/media/732750/Research_and_Markets.jpg?p=facebook", "publishedAt": "2018-09-06T18:00:00Z", "content": "DUBLIN, Sept. 6, 2018 /PRNewswire/ -- The \"Flavonoids in Dietary Supplements Market: By form; By Flavonoid Class; By Application &amp; By Geography - Forecast 2017-2022\" report has been added to ResearchAndMarkets.com's offering. Flavonoids are generally prod\u2026 [+3989 chars]"}, {"source": {"id": null, "name": "Fiercepharma.com"}, "author": "Angus Liu", "title": "Novartis finally unloads 300 troubled U.S. generics to India\u2019s Aurobindo for $1B", "description": "Novartis has inked its deal to sell a big chunk of its Sandoz U.S. business. The deal relieves Novartis of a troubled franchise\u2014including some easy-to-copy generics and several manufacturing plants\u2014while boosting buyer Aurobindo to the second-largest generic \u2026", "url": "https://www.fiercepharma.com/pharma/novartis-sells-some-300-sandoz-u-s-drugs-to-india-s-aurobindo-for-1b?utm_source=internal&utm_medium=rss", "urlToImage": "https://qtxasset.com/fiercepharma/1536240043/7263-Novartis%20Building.jpg/7263-Novartis%20Building.jpg?2rE_1AE.cDAtW4PDF3urR7jP7zImZ1Sa", "publishedAt": "2018-09-06T13:22:03Z", "content": "Novartis has its U.S. generics sale. After shopping pieces of its troubled Sandoz business for months, the Swiss drugmaker has unloaded a big chunk\u2014including some easy-to-copy generics and several manufacturing plants\u2014for $1 billion to India-based Aurobindo P\u2026 [+4102 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Carolyn Y Johnson, Carolyn Y Johnson", "title": "Major US hospitals launch not-for-profit drug company to battle pharmaceutical corporations", "description": "Organisation hopes to establish price transparency and stable supplies for essential medicines", "url": "https://www.independent.co.uk/news/world/americas/us-healthcare-hospitals-drug-company-not-for-profit-pharmaceutical-corporations-civica-rx-a8525236.html", "urlToImage": "https://static.independent.co.uk/s3fs-public/thumbnails/image/2018/09/06/11/healthcare-costs.jpg", "publishedAt": "2018-09-06T12:10:48Z", "content": "A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a mission-driven, not-for-profit generic drug company, Civica Rx, to take some control over the drug supply. Backed by se\u2026 [+36024 chars]"}, {"source": {"id": null, "name": "Seekingalpha.com"}, "author": "SA Transcripts", "title": "Johnson & Johnson (JNJ) Management Presents at Barclays Global Consumer Staples Conference Call (Transcript)", "description": "Johnson &amp; Johnson (NYSE:JNJ) Barclays Global Consumer Staples Conference Call September 06, 2018 12:45 PM ET Executives Jorge Mesquita - Executive Vice Pres", "url": "https://seekingalpha.com/article/4204766-johnson-and-johnson-jnj-management-presents-barclays-global-consumer-staples-conference-call", "urlToImage": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "publishedAt": "2018-09-06T21:50:07Z", "content": "Johnson &amp; Johnson (NYSE: JNJ ) Barclays Global Consumer Staples Conference Call September 6, 2018 12:45 PM ET Executives Jorge Mesquita - Executive Vice President, Worldwide Chairman for Consumer Analysts Geoff Meacham - Barclays Geoff Meacham Okay. Welco\u2026 [+34609 chars]"}, {"source": {"id": null, "name": "Seekingalpha.com"}, "author": "SA Transcripts", "title": "Johnson & Johnson (JNJ) Management Presents at Barclays Global Consumer Staples Conference Call (Transcript)", "description": "Johnson &amp; Johnson (NYSE:JNJ) Barclays Global Consumer Staples Conference Call September 06, 2018 12:45 PM ET Executives Jorge Mesquita - Executive Vice Pres", "url": "https://seekingalpha.com/article/4204766-johnson-and-johnson-jnj-management-presents-barclays-global-consumer-staples-conference-call", "urlToImage": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "publishedAt": "2018-09-06T21:50:07Z", "content": "Johnson &amp; Johnson (NYSE: JNJ ) Barclays Global Consumer Staples Conference Call September 6, 2018 12:45 PM ET Executives Jorge Mesquita - Executive Vice President, Worldwide Chairman for Consumer Analysts Geoff Meacham - Barclays Geoff Meacham Okay. Welco\u2026 [+34609 chars]"}]}